Innovating Anticancer Chemistry and Medicinal Discoveries at the Forefront of Drug Research
Dr. Yousef Najajreh is a distinguished Associate Professor of Chemistry and Medicinal Chemistry at Al-Quds University, Jerusalem, Palestine. He leads groundbreaking research in the design and synthesis of novel anticancer agents and cytotoxic compounds.
With a career spanning over two decades, Dr. Najajreh has held significant leadership positions including serving as Dean of Scientific Research and Dean of the Faculty of Pharmacy at Al-Quds University. His expertise encompasses rational drug design, platinum-based prodrugs, heterocyclic systems, and novel chemical modulators of cellular processes.
The Hebrew University of Jerusalem
Specialization in Anticancer Agents
The Hebrew University of Jerusalem
Focus on Drug Design and Synthesis
Bethlehem University
Foundation in Chemical Sciences
Al-Quds University
Al-Quds University
Pioneering research at the intersection of medicinal chemistry, drug design, and oncology to develop next-generation anticancer therapeutics.
Design and synthesis of novel anticancer agents targeting various cancer types including leukemia and resistant cancers. Focus on improving efficacy and reducing side effects.
Development of platinum-based prodrug systems with enhanced selectivity and reduced toxicity profiles, advancing beyond traditional cisplatin derivatives.
Exploration of heterocyclic scaffolds as privileged structures in medicinal chemistry for developing potent and selective therapeutic agents.
Computational and structure-based approaches to design molecules with optimized pharmacological profiles and improved drug-like properties.
Development of novel chemical modulators targeting key cellular processes including cell division, apoptosis, and signal transduction pathways.
Improving pharmacological profiles of approved drugs through structural modifications to enhance efficacy, bioavailability, and safety.
The Anticancer Drugs Research Lab at Al-Quds University is dedicated to the discovery and development of novel therapeutic agents for cancer treatment. Under Dr. Najajreh's leadership, the lab focuses on translating fundamental research into potential clinical applications.
Author and co-author of more than 30 research articles, reviews, and book chapters in prestigious international scientific journals.
World Intellectual Property Organization (WIPO-PCT) patent for compounds with potential application in treating leukemia and resistant cancers through inhibition of cell division mechanisms.
Development of a new class of platinum complexes with improved selectivity profiles and reduced off-target toxicity in normal cells.
Comprehensive study on the role of heterocyclic compounds in developing potent anticancer agents with favorable drug-like properties.
A comprehensive review of modern approaches in anticancer drug design, including computational methods and structure-activity relationships.
Novel approaches to targeting cell division machinery using small molecule inhibitors with improved pharmacological profiles.
Committed to nurturing the next generation of pharmaceutical scientists and medicinal chemists through rigorous academic training.
Advanced principles of drug design, structure-activity relationships, and pharmacophore modeling.
Fundamentals of drug synthesis, formulation, and quality control in pharmaceutical sciences.
Comprehensive organic chemistry covering reaction mechanisms, synthesis, and spectroscopy.
From target identification to clinical trials: the complete drug development pipeline.
"Dr. Najajreh's guidance transformed my understanding of medicinal chemistry. His passion for anticancer research is truly inspiring and his mentorship has been invaluable to my career."
"Working in Dr. Najajreh's lab was a privilege. His dedication to both research excellence and student development sets him apart as an exceptional mentor and scientist."
International patent recognition for novel cancer cell division inhibitors
Recognition for outstanding contributions to medicinal chemistry research
Multiple awards for collaborative research with international institutions
Serving on editorial boards of international medicinal chemistry and pharmaceutical journals
Active reviewer for leading journals including Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry, and Bioorganic & Medicinal Chemistry
Invited speaker at World Science Forum and international medicinal chemistry conferences
Active research collaborations with institutions worldwide in anticancer drug development
Interested in collaboration, research opportunities, or academic inquiries? Feel free to reach out.
Faculty of Pharmacy
Al-Quds University
Jerusalem, Palestine
Anticancer Drugs Research Lab
Faculty of Pharmacy Building